Augmented capillary leak during isolated hepatic perfusion (IHP) occurs via tumor necrosis factor-independent mechanisms

H. Richard Alexander, Charles K. Brown, David L. Bartlett, Steven K. Libutti, William D. Figg, Sangeeta Raje, Ewa Turner

Research output: Contribution to journalArticle

26 Citations (Scopus)

Abstract

Isolated organ perfusion of the liver or extremity with tumor necrosis factor (TNF) and melphalan results in regression of bulky tumors in the majority of patients. The efficacy of TNF in this setting is not known, although data suggest that it may exert antitumor effects primarily on tumor- associated neovasculature. We studied the effects of TNF on capillary leak in liver and tumor tissue during isolated hepatic perfusion (IHP) with melphalan. Twenty-seven patients with unresectable cancer confined to the liver underwent a 60-min hyperthermic IHP using 1.5 mg/kg melphalan alone (n = 7) or with 1.0 mg of TNF (n = 20). Complete vascular isolation was confirmed in all patients using an intraoperative leak monitoring I-131 radiolabeled albumin technique. Samples of tumor and liver were collected just prior to and immediately after IHP. There was no difference in I-131 radiolabeled cpm/g of tissue (cpm) in liver versus tumor at baseline (P2 = 0.44). After IHP, I-131 albumin cpm were higher in tumor versus liver (10,999 ± 1,976 versus 3,821 ± 780, respectively; P2 < 0.005). However, I-131 albumin cpm in tumor were not effected by TNF (11,636 ± 2,518 with TNF versus 9,180 ± 2,674 without TNF; P2 = 0.59). TNF did not affect melphalan concentrations in tumor (1,883 ± 540 ng/g versus 1,854 ± 861 ng/g without TNF; P2 = 0.9). Capillary leak, as reflected by diffusion of I-131 radiolabeled albumin into the interstitial space, is comparable in liver and tumor before IHP but is significantly higher in tumor after IHP. The increased diffusion in the capillary tumor bed must occur through TNF- independent mechanisms such as intrinsic features of tumor neovasculature, hyperthermia, or other unrecognized perfusion-related factors. These data indicate that TNF must continue to be critically evaluated in clinical trials before it is routinely used with melphalan in isolated organ perfusion.

Original languageEnglish (US)
Pages (from-to)2357-2362
Number of pages6
JournalClinical Cancer Research
Volume4
Issue number10
StatePublished - Oct 1998
Externally publishedYes

Fingerprint

Tumor Necrosis Factor-alpha
Perfusion
Liver
Melphalan
Neoplasms
Albumins
Intraoperative Monitoring
Blood Vessels
Fever
Extremities
Clinical Trials

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Alexander, H. R., Brown, C. K., Bartlett, D. L., Libutti, S. K., Figg, W. D., Raje, S., & Turner, E. (1998). Augmented capillary leak during isolated hepatic perfusion (IHP) occurs via tumor necrosis factor-independent mechanisms. Clinical Cancer Research, 4(10), 2357-2362.

Augmented capillary leak during isolated hepatic perfusion (IHP) occurs via tumor necrosis factor-independent mechanisms. / Alexander, H. Richard; Brown, Charles K.; Bartlett, David L.; Libutti, Steven K.; Figg, William D.; Raje, Sangeeta; Turner, Ewa.

In: Clinical Cancer Research, Vol. 4, No. 10, 10.1998, p. 2357-2362.

Research output: Contribution to journalArticle

Alexander, HR, Brown, CK, Bartlett, DL, Libutti, SK, Figg, WD, Raje, S & Turner, E 1998, 'Augmented capillary leak during isolated hepatic perfusion (IHP) occurs via tumor necrosis factor-independent mechanisms', Clinical Cancer Research, vol. 4, no. 10, pp. 2357-2362.
Alexander HR, Brown CK, Bartlett DL, Libutti SK, Figg WD, Raje S et al. Augmented capillary leak during isolated hepatic perfusion (IHP) occurs via tumor necrosis factor-independent mechanisms. Clinical Cancer Research. 1998 Oct;4(10):2357-2362.
Alexander, H. Richard ; Brown, Charles K. ; Bartlett, David L. ; Libutti, Steven K. ; Figg, William D. ; Raje, Sangeeta ; Turner, Ewa. / Augmented capillary leak during isolated hepatic perfusion (IHP) occurs via tumor necrosis factor-independent mechanisms. In: Clinical Cancer Research. 1998 ; Vol. 4, No. 10. pp. 2357-2362.
@article{70ae8d1ffb7a4f28beb6202d895e5a66,
title = "Augmented capillary leak during isolated hepatic perfusion (IHP) occurs via tumor necrosis factor-independent mechanisms",
abstract = "Isolated organ perfusion of the liver or extremity with tumor necrosis factor (TNF) and melphalan results in regression of bulky tumors in the majority of patients. The efficacy of TNF in this setting is not known, although data suggest that it may exert antitumor effects primarily on tumor- associated neovasculature. We studied the effects of TNF on capillary leak in liver and tumor tissue during isolated hepatic perfusion (IHP) with melphalan. Twenty-seven patients with unresectable cancer confined to the liver underwent a 60-min hyperthermic IHP using 1.5 mg/kg melphalan alone (n = 7) or with 1.0 mg of TNF (n = 20). Complete vascular isolation was confirmed in all patients using an intraoperative leak monitoring I-131 radiolabeled albumin technique. Samples of tumor and liver were collected just prior to and immediately after IHP. There was no difference in I-131 radiolabeled cpm/g of tissue (cpm) in liver versus tumor at baseline (P2 = 0.44). After IHP, I-131 albumin cpm were higher in tumor versus liver (10,999 ± 1,976 versus 3,821 ± 780, respectively; P2 < 0.005). However, I-131 albumin cpm in tumor were not effected by TNF (11,636 ± 2,518 with TNF versus 9,180 ± 2,674 without TNF; P2 = 0.59). TNF did not affect melphalan concentrations in tumor (1,883 ± 540 ng/g versus 1,854 ± 861 ng/g without TNF; P2 = 0.9). Capillary leak, as reflected by diffusion of I-131 radiolabeled albumin into the interstitial space, is comparable in liver and tumor before IHP but is significantly higher in tumor after IHP. The increased diffusion in the capillary tumor bed must occur through TNF- independent mechanisms such as intrinsic features of tumor neovasculature, hyperthermia, or other unrecognized perfusion-related factors. These data indicate that TNF must continue to be critically evaluated in clinical trials before it is routinely used with melphalan in isolated organ perfusion.",
author = "Alexander, {H. Richard} and Brown, {Charles K.} and Bartlett, {David L.} and Libutti, {Steven K.} and Figg, {William D.} and Sangeeta Raje and Ewa Turner",
year = "1998",
month = "10",
language = "English (US)",
volume = "4",
pages = "2357--2362",
journal = "Clinical Cancer Research",
issn = "1078-0432",
publisher = "American Association for Cancer Research Inc.",
number = "10",

}

TY - JOUR

T1 - Augmented capillary leak during isolated hepatic perfusion (IHP) occurs via tumor necrosis factor-independent mechanisms

AU - Alexander, H. Richard

AU - Brown, Charles K.

AU - Bartlett, David L.

AU - Libutti, Steven K.

AU - Figg, William D.

AU - Raje, Sangeeta

AU - Turner, Ewa

PY - 1998/10

Y1 - 1998/10

N2 - Isolated organ perfusion of the liver or extremity with tumor necrosis factor (TNF) and melphalan results in regression of bulky tumors in the majority of patients. The efficacy of TNF in this setting is not known, although data suggest that it may exert antitumor effects primarily on tumor- associated neovasculature. We studied the effects of TNF on capillary leak in liver and tumor tissue during isolated hepatic perfusion (IHP) with melphalan. Twenty-seven patients with unresectable cancer confined to the liver underwent a 60-min hyperthermic IHP using 1.5 mg/kg melphalan alone (n = 7) or with 1.0 mg of TNF (n = 20). Complete vascular isolation was confirmed in all patients using an intraoperative leak monitoring I-131 radiolabeled albumin technique. Samples of tumor and liver were collected just prior to and immediately after IHP. There was no difference in I-131 radiolabeled cpm/g of tissue (cpm) in liver versus tumor at baseline (P2 = 0.44). After IHP, I-131 albumin cpm were higher in tumor versus liver (10,999 ± 1,976 versus 3,821 ± 780, respectively; P2 < 0.005). However, I-131 albumin cpm in tumor were not effected by TNF (11,636 ± 2,518 with TNF versus 9,180 ± 2,674 without TNF; P2 = 0.59). TNF did not affect melphalan concentrations in tumor (1,883 ± 540 ng/g versus 1,854 ± 861 ng/g without TNF; P2 = 0.9). Capillary leak, as reflected by diffusion of I-131 radiolabeled albumin into the interstitial space, is comparable in liver and tumor before IHP but is significantly higher in tumor after IHP. The increased diffusion in the capillary tumor bed must occur through TNF- independent mechanisms such as intrinsic features of tumor neovasculature, hyperthermia, or other unrecognized perfusion-related factors. These data indicate that TNF must continue to be critically evaluated in clinical trials before it is routinely used with melphalan in isolated organ perfusion.

AB - Isolated organ perfusion of the liver or extremity with tumor necrosis factor (TNF) and melphalan results in regression of bulky tumors in the majority of patients. The efficacy of TNF in this setting is not known, although data suggest that it may exert antitumor effects primarily on tumor- associated neovasculature. We studied the effects of TNF on capillary leak in liver and tumor tissue during isolated hepatic perfusion (IHP) with melphalan. Twenty-seven patients with unresectable cancer confined to the liver underwent a 60-min hyperthermic IHP using 1.5 mg/kg melphalan alone (n = 7) or with 1.0 mg of TNF (n = 20). Complete vascular isolation was confirmed in all patients using an intraoperative leak monitoring I-131 radiolabeled albumin technique. Samples of tumor and liver were collected just prior to and immediately after IHP. There was no difference in I-131 radiolabeled cpm/g of tissue (cpm) in liver versus tumor at baseline (P2 = 0.44). After IHP, I-131 albumin cpm were higher in tumor versus liver (10,999 ± 1,976 versus 3,821 ± 780, respectively; P2 < 0.005). However, I-131 albumin cpm in tumor were not effected by TNF (11,636 ± 2,518 with TNF versus 9,180 ± 2,674 without TNF; P2 = 0.59). TNF did not affect melphalan concentrations in tumor (1,883 ± 540 ng/g versus 1,854 ± 861 ng/g without TNF; P2 = 0.9). Capillary leak, as reflected by diffusion of I-131 radiolabeled albumin into the interstitial space, is comparable in liver and tumor before IHP but is significantly higher in tumor after IHP. The increased diffusion in the capillary tumor bed must occur through TNF- independent mechanisms such as intrinsic features of tumor neovasculature, hyperthermia, or other unrecognized perfusion-related factors. These data indicate that TNF must continue to be critically evaluated in clinical trials before it is routinely used with melphalan in isolated organ perfusion.

UR - http://www.scopus.com/inward/record.url?scp=0031784173&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0031784173&partnerID=8YFLogxK

M3 - Article

C2 - 9796965

AN - SCOPUS:0031784173

VL - 4

SP - 2357

EP - 2362

JO - Clinical Cancer Research

JF - Clinical Cancer Research

SN - 1078-0432

IS - 10

ER -